An Open Label Trial of Sustained-release Cytarabine (DepoCyt™) for the Intrathecal Treatment of Solid Tumor Neoplastic Meningitis
- 1 January 2002
- journal article
- clinical trial
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 57 (3), 231-239
- https://doi.org/10.1023/a:1015752331041
Abstract
Drugs currently available for intrathecal administration are cleared rapidly from the CSF. DepoCyt is a slow-release formulation of cytarabine that maintains cytotoxic concentrations of free...Keywords
This publication has 18 references indexed in Scilit:
- A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.1999
- Randomized Trial of a Slow-Release Versus a Standard Formulation of Cytarabine for the Intrathecal Treatment of Lymphomatous MeningitisJournal of Clinical Oncology, 1999
- Prolongation of drug exposure in cerebrospinal fluid by encapsulation into DepoFoam.1993
- Central Nervous System Pharmacology of Antileukemic DrugsJournal of Pediatric Hematology/Oncology, 1989
- MULTIVESICULAR LIPOSOMES CONTAINING 1-BETA-D-ARABINOFURANOSYLCYTOSINE FOR SLOW-RELEASE INTRATHECAL THERAPY1987
- Cytosine arabinoside cerebrospinal fluid kineticsClinical Pharmacology & Therapeutics, 1984
- Carcinomatous Leptomeningitis in Small Cell Lung CancerMedicine, 1982
- CONCENTRATION X TIME METHOTREXATE VIA A SUBCUTANEOUS RESERVOIR - LESS TOXIC REGIMEN FOR INTRA-VENTRICULAR CHEMOTHERAPY OF CENTRAL NERVOUS-SYSTEM NEOPLASMS1978
- Methotrexate: Distribution in Cerebrospinal Fluid after Intravenous, Ventricular and Lumbar InjectionsNew England Journal of Medicine, 1975
- Cytosine Arabinoside (NSC 63878) Toxicity and Antitumor Activity in Human Solid TumorsOncology, 1974